Clinical Trial: Adult Primary Insomnia Polysomnographic Study


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Adult Primary Insomnia Polysomnographic Study

This study is not yet open for patient recruitment.

Sponsored by:	Merck
Information provided by:	Merck

Purpose

The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.

Condition	Treatment or Intervention	Phase
Primary Insomnia		Phase II Phase III

MedlinePlus related topics: Sleep Disorders

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment

Eligibility

Ages Eligible for Study: 18 Years - 64 Years, Genders Eligible for Study: Both

Criteria

Inclusion Criteria:

Adult patients with a diagnosis of primary insomnia and in good physical and mental health

Location Information

Toll Free Number 1-888-577-8839

More Information

Study ID Numbers: 2004_087
Record last reviewed: October 2004
Record first received: October 21, 2004
ClinicalTrials.gov Identifier: NCT00094627
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-11-09

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services